Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07740564 |
| Consolidated Lead Sponsor | Ocumension Therapeutics (Suzhou) Co |
| Therapeutic Condition Cohort | Ophthalmology and Sensory |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 842 participants (ESTIMATED) |
| Registered Start Date | 2026-08-25 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Affiliated Hospital of Anhui Medical University | Hefei, China | Open Hospital Dossier -> |
| Peking University People's Hospital | Beijing, China | Open Hospital Dossier -> |
| Peking Union Medical College Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital Of Fujian Medical University | Fuzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Ophthalmology and Sensory Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.